The vital factors aiding the expansion of this market embrace the increasing utility of biomarkers for diagnostic functions and new initiatives for biomarker analysis. The biomarker technologies market is predicted to achieve USD 74.51 billion in 2022, at a CAGR of 9.7% throughout the forecast period. The main target on biomarker analysis within the field of genetic science is growing with the arrival of innovative technologies.
Read »
|